These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. A common MUC5B promoter polymorphism and pulmonary fibrosis. Seibold MA; Wise AL; Speer MC; Steele MP; Brown KK; Loyd JE; Fingerlin TE; Zhang W; Gudmundsson G; Groshong SD; Evans CM; Garantziotis S; Adler KB; Dickey BF; du Bois RM; Yang IV; Herron A; Kervitsky D; Talbert JL; Markin C; Park J; Crews AL; Slifer SH; Auerbach S; Roy MG; Lin J; Hennessy CE; Schwarz MI; Schwartz DA N Engl J Med; 2011 Apr; 364(16):1503-12. PubMed ID: 21506741 [TBL] [Abstract][Full Text] [Related]
29. Real-life experiences in a single center: efficacy of pirfenidone in idiopathic pulmonary fibrosis and fibrotic idiopathic non-specific interstitial pneumonia patients. Feng H; Zhao Y; Li Z; Kang J Ther Adv Respir Dis; 2020; 14():1753466620963015. PubMed ID: 33070705 [TBL] [Abstract][Full Text] [Related]
30. Interstitial pneumonia induced by bleomycin treatment is exacerbated in Angptl2-deficient mice. Motokawa I; Endo M; Terada K; Horiguchi H; Miyata K; Kadomatsu T; Morinaga J; Sugizaki T; Ito T; Araki K; Morioka MS; Manabe I; Samukawa T; Watanabe M; Inoue H; Oike Y Am J Physiol Lung Cell Mol Physiol; 2016 Oct; 311(4):L704-L713. PubMed ID: 27542805 [TBL] [Abstract][Full Text] [Related]
31. [Current status of the prevention and treatment of intersititial lung diseases by traditional Chinese medicine]. Tao K; Zhou XY Zhongguo Zhong Xi Yi Jie He Za Zhi; 1997 Sep; 17(9):574-6. PubMed ID: 10322883 [No Abstract] [Full Text] [Related]
34. [Polyarteritis nodosa, cyclophosphamide and interstitial lung disease]. Mera V Med Clin (Barc); 2000 Feb; 114(4):158. PubMed ID: 10734629 [No Abstract] [Full Text] [Related]
35. Clinical features and genetic analysis of surfactant protein C in adult-onset familial interstitial pneumonia. Setoguchi Y; Ikeda T; Fukuchi Y Respirology; 2006 Jan; 11 Suppl():S41-5. PubMed ID: 16423270 [TBL] [Abstract][Full Text] [Related]
36. Interstitial lung disease in systemic sclerosis: pathophysiology, current and new advances in therapy. Jain S; Shahane A; Derk CT Inflamm Allergy Drug Targets; 2012 Aug; 11(4):266-77. PubMed ID: 22506881 [TBL] [Abstract][Full Text] [Related]
39. To clot or not to clot, that is the question in pulmonary fibrosis. Strieter RM Am J Respir Crit Care Med; 2003 Jun; 167(12):1589-90. PubMed ID: 12796052 [No Abstract] [Full Text] [Related]
40. [Merit and demerit of steroid therapy of interstitial lung disease]. Kondo A Nihon Naika Gakkai Zasshi; 1994 May; 83(5):745-51. PubMed ID: 7964015 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]